EEST | Duell Oyj | Financial statement release This company announcement is a summary of Duell's 2025 financial year report for September 2024-August 2025. The complete report is ...

In APPLAUSE-IgAN final analysis, Fabhalta demonstrated statistically significant, clinically meaningful improvement in estimated glomerular filtration rate (eGFR) slope vs. placebo over two years1eGFR ...

MWIC is an indicator-variable for each of the 21 material weaknesses in Internal Control categorized by Audit Analytics as ...